Adipokines at the crossroads of obesity and mesenchymal stem cell therapy

참고문헌 (100)

1. Parekkadan, B., "Mesenchymal stem cells as therapeutics", Annu. Rev. Biomed. Eng, 12, pp.87~117 (2010)
2. Dominici, M., "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement", Cytotherapy, 8, pp.315~317 (2006)
3. Farahani, R. M., "Platelet-derived growth factor receptor alpha as a marker of mesenchymal stem cells in development and stem cell biology", Stem Cells Int, 2015, pp.362753~ (2015)
4. Hara, A., "Meflin defines mesenchymal stem cells and", or their early progenitors with multilineage differentiation capacity, 2021, pp.26, 495~512
5. Boland, L., "Translating MSC therapy in the age of obesity", Front. Immunol, 13, pp.943333~ (2022)
6. Louwen, F., "Insight into the development of obesity : functional alterations of adipose-derived mesenchymal stem cells", Obes. Rev, 19, pp.888~904 (2018)
7. Fasshauer, M., "Adipokines in health and disease", Trends Pharmacol. Sci, 36, pp.461~470 (2015)
8. Oestreich, A. K., "Is obesity a disease of stem cells?", Cell Stem Cell, 27, pp.15~18 (2020)
9. Perez, L. M., "Altered metabolic and stemness capacity of adipose tissuederived stem cells from obese mouse and human", PLoS ONE, 10, pp.e0123397~ (2015)
10. Alessio, N., "Obesity is associated with senescence of mesenchymal stromal cells derived from bone marrow, subcutaneous and visceral fat of young mice", Aging, 12, pp.12609~12621 (2020)
11. Patel, R. S., "Adipose-derived stem cells from lean and obese humans show depot specific differences in their stem cell markers, exosome contents and senescence : role of protein kinase C delta(PKCδ)in adipose stem cell niche", Stem Cell Investig, 3, pp.2~ (2016)
12. Wu, C. L., "Diet-induced obesity alters the differentiation potential of stem cells isolated from bone marrow, adipose tissue and infrapatellar fat pad : the effects of free fatty acids", Int. J. Obes, 37, pp.1079~1087 (2013)
13. Oliva-Olivera, W., "Differences in the osteogenic differentiation capacity of omental adipose-derived stem cells in obese patients with and without metabolic syndrome", Endocrinology, 156, pp.4492~4501 (2015)
14. De Girolamo, L., "Stemness and osteogenic and adipogenic potential are differently impaired in subcutaneous and visceral adipose derived stem cells(ASCs)isolated from obese donors", Int. J. Immunopathol. Pharmacol, 26, pp.11~21 (2013)
15. Pérez, L. M., "Obesity-driven alterations in adipose-derived stem cells are partially restored by weight loss", Obesity, 24, pp.661~669 (2016)
16. Oñate, B., "Stem cells isolated from adipose tissue of obese patients show changes in their transcriptomic profile that indicate loss in stemcellness and increased commitment to an adipocyte-like phenotype", BMC Genomics, 14, pp.625~ (2013)
17. Jeffery, E., "Rapid depotspecific activation of adipocyte precursor cells at the onset of obesity", Nat. Cell Biol, 17, pp.376~385 (2015)
18. Gesta, S., "Developmental origin of fat: tracking obesity to its source", Cell, 131, pp.242~256 (2007)
19. Kizilay Mancini, O., "Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cellmediated T-cell suppression", Stem Cell Res. Ther, 6, pp.140~ (2015)
20. Strong, A. L., "Human adipose stromal", stem cells from obese donors show reduced efficacy in halting disease progression in the experimental autoimmune encephalomyelitis model of multiple sclerosis, 2016, pp.34, 614~626
21. Lee, M. J., "Proteomic analysis of tumor necrosis factor-alpha-induced secretome of human adipose tissue-derived mesenchymal stem cells", J. Proteome Res, 9, pp.1754~1762 (2010)
22. Klomjit, N., "Effects of obesity on reparative function of human adipose tissue-derived mesenchymal stem cells on ischemic murine kidneys", Int. J. Obes, 46, pp.1222~1233 (2022)
23. Pérez, L. M., "Obese-derived ASCs show impaired migration and angiogenesis properties", Arch. Physiol. Biochem, 119, pp.195~201 (2013)
24. Oñate, B., "The subcutaneous adipose tissue reservoir of functionally active stem cells is reduced in obese patients", FASEB J, 26, pp.4327~4336 (2012)
25. Ayaz-Guner, S., "A comparative study on normal and obese mice indicates that the secretome of mesenchymal stromal cells is influenced by tissue environment and physiopathological conditions", Cell Commun. Signal, 18, pp.118~ (2020)
26. Acar, M. B., "Obesity induced by high-fat diet is associated with critical changes in biological and molecular functions of mesenchymal stromal cells present in visceral adipose tissue", Aging, 12, pp.24894~24913 (2020)
27. Gregor, M. F., "Inflammatory mechanisms in obesity", Annu. Rev. Immunol, 29, pp.415~445 (2011)
28. Kastrinaki, M. C., "Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis", Ann. Rheum. Dis, 67, pp.741~749 (2008)
29. Murphy, J. M., "Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis", Arthritis Rheum, 46, pp.704~713 (2002)
30. Zhang, Y., "Age-related changes in the inflammatory status of human mesenchymal stem cells : implications for cell therapy", Stem Cell Rep, 16, pp.694~707 (2021)
31. Feng, G., "Repeated stimulation by LPS promotes the senescence of DPSCs via TLR4", MyD88-NF-κB-p53, Cytotechnology, pp.2018, 70[DOI]
32. Michelet, X., "Metabolic reprogramming of natural killer cells in obesity limits antitumor responses", Nat. Immunol, 19, pp.1330~1340 (2018)
33. Terje S. Larsen, "Impact of Obesity-Related Inflammation on Cardiac Metabolism and Function", 지질·동맥경화학회지, 10(1), pp.8~23 (2021), 한국지질동맥경화학회[DOI]
34. Nguyen, L. T., "Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow-derived mesenchymal stem", stromal cells, 2021, pp.10, 1266~1278
35. Fillmore, N., "Effect of fatty acids on human bone marrow mesenchymal stem cell energy metabolism and survival", PLoS ONE, 10, pp.e0120257~ (2015)
36. Contreras-Lopez, R., "HIF1α-dependent metabolic reprogramming governs mesenchymal stem", stromal cell immunoregulatory functions, 2020, pp.34, 8250~8264
37. Zhang, Y., "Mitochondrial respiration regulates adipogenic differentiation of human mesenchymal stem cells", PLoS ONE, 8, pp.e77077~ (2013)
38. Lin, J. H., "Palmitic acid methyl ester induces G2", M arrest in human bone marrow-derived mesenchymal stem cells via the p53, Stem Cells Int, pp.2019, 2019[DOI]
39. Blüher, M., "From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century", Metabolism, 64, pp.131~145 (2015)
40. Duc‑Vinh Pham, "Recent insights on modulation of infl ammasomes by adipokines: a critical event for the pathogenesis of obesity and metabolism-associated diseases", Archives of Pharmacal Research, 43(10), pp.997~1016 (2020), 대한약학회[DOI]
41. Zhou, B. O., "Leptin-receptorexpressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow", Cell Stem Cell, 15, pp.154~168 (2014)
42. Zhang, B., "Leptin potentiates BMP9-induced osteogenic differentiation of mesenchymal stem cells through the activation of JAK", STAT signaling, 2020, pp.29, 498~510
43. Zheng, B., "Increased osteogenesis in osteoporotic bone marrow stromal cells by overexpression of leptin", Cell Tissue Res, 361, pp.845~856 (2015)
44. Han, G., "Osteogenic differentiation of bone marrow mesenchymal stem cells by adenovirus-mediated expression of leptin", Regul. Pept, 163, pp.107~112 (2010)
45. Zheng, B., "Leptin overexpression in bone marrow stromal cells promotes periodontal regeneration in a rat model of osteoporosis", J. Periodontol, 88, pp.808~818 (2017)
46. Gkastaris, K., "Obesity, osteoporosis and bone metabolism", J. Musculoskelet. Neuronal Interact, 20, pp.372~381 (2020)
47. Brown, M. L., "Delayed fracture healing and increased callus adiposity in a C57BL", 6J murine model of obesity-associated type 2 diabetes mellitus, 2014, pp.9, e99656~
48. Hess, R., "High affinity leptin receptors are present in human mesenchymal stem cells(MSCs)derived from control and osteoporotic donors", J. Cell. Biochem, 94, pp.50~57 (2005)
49. Zhang, Z. M., "Osteogenic potential and responsiveness to leptin of mesenchymal stem cells between postmenopausal women with osteoarthritis and osteoporosis", J. Orthop. Res, 27, pp.1067~1073 (2009)
50. Yue, R., "Leptin receptor promotes adipogenesis and reduces osteogenesis by regulating mesenchymal stromal cells in adult bone marrow", Cell Stem Cell, 18, pp.782~796 (2016)
51. Moeinabadi-Bidgoli, K., "Translational insights into stem cell preconditioning : from molecular mechanisms to preclinical applications", Biomed. Pharmacother, 142, pp.112026~ (2021)
52. Sanchez, C., "Epigenetic reprogramming of IGF1and leptin genes by serum deprivation in multipotential mesenchymal stromal cells", Stem Cells, 27, pp.375~382 (2009)
53. Hu, X., "Leptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxia preconditioning", Stem Cells, 32, pp.2702~2713 (2014)
54. Chen, P., "Hypoxia preconditioned mesenchymal stem cells prevent cardiac fibroblast activation and collagen production via leptin", PLoS ONE, 9, pp.e103587~ (2014)
55. Yang, F., "Leptin increases mitochondrial OPA1 via GSK3-mediated OMA1ubiquitination to enhance therapeutic effects of mesenchymal stem cell transplantation", Cell Death Dis, 9, pp.556~ (2018)
56. Chen, H., "Leptin and neutrophil-activating peptide 2 promote mesenchymal stem cell senescence through activation of the phosphatidylinositol 3-kinase", akt pathway in patients with systemic lupus erythematosus, 2015, pp.67, 2383~2393
57. Laschober, G. T., "Leptin receptor", CD295 is upregulated on primary human mesenchymal stem cells of advancing biological age and distinctly marks the subpopulation of dying cells, 2009, pp.44, 57~62
58. Zhou, Z., "Leptin differentially regulate STAT3 activation in ob", ob mouse adipose mesenchymal stem cells, 2012, pp.9, 109~
59. Pham, D. -V., "Tumor metabolic reprogramming by adipokines as a critical driver of obesity-associated cancer progression", Int. J. Mol. Sci, 22, pp.1444~ (2021)
60. Yamauchi, T., "Adiponectin receptors : a review of their structure, function and how they work", Best. Pract. Res. Clin. Endocrinol. Metab, 28, pp.15~23 (2014)
61. Yang, S., "Effect of adiponectin secreted from adipose-derived stem cells on bone-fat balance and bone defect healing", J. Tissue Eng. Regen. Med, 13, pp.2055~2066 (2019)
62. Lin, Y. Y., "Adiponectin receptor 1 regulates bone formation and osteoblast differentiation by GSK-3β", β-catenin signaling in mice, 2014, pp.64, 147~154
63. Wang, Y., "Human amnion-derived mesenchymal stem cells enhance the osteogenic differentiation of human adipose-derived stem cells by promoting adiponectin excretion via the APPL1-ERK1", 2 signaling pathway, 2020, pp.72, 296~304
64. Chen, T., "Adiponectin enhances osteogenic differentiation in human adipose-derived stem cells by activating the APPL1-AMPK signaling pathway", Biochem. Biophys. Res. Commun, 461, pp.237~242 (2015)
65. Pu, Y., "Adiponectin promotes human jaw bone marrow mesenchymal stem cell chemotaxis via CXCL1 and CXCL8", J. Cell. Mol. Med, 21, pp.1411~1419 (2017)
66. Yu, L., "Adiponectin regulates bone marrow mesenchymal stem cell niche through a unique signal transduction pathway : an approach for treating bone disease in diabetes", Stem Cells, 33, pp.240~252 (2015)
67. McGinley, L. M., "Mesenchymal stem cell survival in the infarcted heart is enhanced by lentivirus vector-mediated heat shock protein 27 expression", Hum. Gene Ther, 24, pp.840~851 (2013)
68. Tian, X. Q., "Globular adiponectin inhibits the apoptosis of mesenchymal stem cells induced by hypoxia and serum deprivation via the adipoR1-mediated pathway", Cell. Physiol. Biochem, 38, pp.909~925 (2016)
69. Zhao, L., "Adiponectin enhances bone marrow mesenchymal stem cell resistance to flow shear stress through AMP-activated protein kinase signaling", Sci. Rep, 6, pp.28752~ (2016)
70. Nakamura, Y., "Adiponectin stimulates exosome release to enhance mesenchymal stem-cell-driven therapy of heart failure in mice", Mol. Ther, 28, pp.2203~2219 (2020)
71. Meng, K., "Adiponectin modified BMSCs alleviate heart fibrosis via inhibition TGF-beta1", Smad in diabetic rats, 2021, pp.9, 644160~
72. Wysocka, M. B., "The role of apelin in cardiovascular diseases, obesity and cancer", Front. Physiol, 9, pp.557~ (2018)
73. Castan-Laurell, I., "The therapeutic potentials of apelin in obesity-associated diseases", Mol. Cell. Endocrinol, 529, pp.111278~ (2021)
74. Boucher, J., "Apelin, a newly identified adipokine up-regulated by insulin and obesity", Endocrinology, 146, pp.1764~1771 (2005)
75. Tapan, S., "Decreased plasma apelin levels in pubertal obese children", J. Pediatr. Endocrinol. Metab, 23, pp.1039~1046 (2010)
76. Li, L., "Hypoxia promotes bone marrow-derived mesenchymal stem cell proliferation through apelin", APJ, Acta Biochim. Biophys. Sin, pp.2015, 47[DOI]
77. Zeng, X., "Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis", Stem Cell Res, 8, pp.357~367 (2012)
78. Hou, J., "Hypoxia preconditioning promotes cardiac stem cell survival and cardiogenic differentiation in vitro involving activation of the HIF-1α", apelin, Stem Cell Res. Ther, pp.2017, 8[DOI]
79. Chen, G., "Apelin-13 pretreatment promotes the cardioprotective effect of mesenchymal stem cells against myocardial infarction by improving their survival", Stem Cells Int, 2022, pp.3742678~ (2022)
80. Chen, L., "Apelin-13 induces mitophagy in bone marrow mesenchymal stem cells to suppress intracellular oxidative stress and ameliorate osteoporosis by activation of AMPK signaling pathway", Free Radic. Biol. Med, 163, pp.356~368 (2021)
81. Liang, D., "Therapeutic efficacy of apelin on transplanted mesenchymal stem cells in hindlimb ischemic mice via regulation of autophagy", Sci. Rep, 6, pp.21914~ (2016)
82. Hang, K., "Apelin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly through Wnt", β-catenin signaling pathway, 2019, pp.10, 189~
83. Zhang, H., "Apelin rejuvenates aged human mesenchymal stem cells by regulating autophagy and improves cardiac protection after infarction", Front. Cell Dev. Biol, 9, pp.628463~ (2021)
84. Yang, C. -M., "Enhanced autophagy of adipose-derived stem cells grown on chitosan substrates", Biores. Open Access, 4, pp.89~96 (2015)
85. Li, L., "Effects of apelin-13 on rat bone marrow-derived mesenchymal stem cell proliferation through the AKT", GSK3β, Int. J. Pept. Res. Ther, pp.2014, 20[DOI]
86. He, Y., "Resistin promotes cardiac homing of mesenchymal stem cells and functional recovery after myocardial ischemia-reperfusion via the ERK1", 2-MMP-9 pathway, 2019, pp.316, H233~h244
87. Rawal, K., "Resistin mitigates stemness and metabolic profile of human adipose-derived mesenchymal stem cells via insulin resistance", Cytokine, 138, pp.155374~ (2021)
88. Tsiklauri, L., "Visfatin alters the cytokine and matrix-degrading enzyme profile during osteogenic and adipogenic MSC differentiation", Osteoarthr. Cartil, 26, pp.1225~1235 (2018)
89. Huang, J. Y., "Visfatin mediates malignant behaviors through adiposederived stem cells intermediary in breast cancer", Cancers, 12, pp.29~ (2019)
90. Yin, L., "Omentin-1 effects on mesenchymal stem cells : proliferation, apoptosis, and angiogenesis in vitro", Stem Cell Res. Ther, 8, pp.224~ (2017)
91. Tan, H. -L., "Human amniotic mesenchymal stem cells-conditioned medium protects mice from high-fat diet-induced obesity", Stem Cell Res. Ther, 12, pp.364~ (2021)
92. Domingues, C. C., "Antioxidantupregulated mesenchymal stem cells reduce inflammation and improve fatty liver disease in diet-induced obesity", Stem Cell Res. Ther, 10, pp.280~ (2019)
93. jaber, H., "The therapeutic effects of adipose-derived mesenchymal stem cells on obesity and its associated diseases in diet-induced obese mice", Sci. Rep, 11, pp.6291~ (2021)
94. Kim, Y. H., "Conditioned medium from tonsil‑derived mesenchymal stem cells promotes adiponectin production", Mol. Med. Rep, 16, pp.6170~6177 (2017)
95. Daltro, P. S., "Therapy with mesenchymal stromal cells or conditioned medium reverse cardiac alterations in a high-fat diet-induced obesity model", Cytotherapy, 19, pp.1176~1188 (2017)
96. Frühbeck, G., "Adiponectin-leptin ratio: a promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk", Adipocyte, 7, pp.57~62 (2018)
97. López-Jaramillo, P., "The role of leptin", adiponectin ratio in metabolic syndrome and diabetes, 2014, pp.18, 37~45
98. Molinero, L. L., "High-fat diet-induced obesity enhances allograft rejection", Transplantation, 100, pp.1015~1021 (2016)
99. Hinden, L., "Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients", PLoS ONE, 14, pp.e0217572~ (2019)
100. Naik, A. S., "The Impact of obesity on allograft failure after kidney transplantation : a competing risks analysis", Transplantation, 100, pp.1963~1969 (2016)

관련 논문AI추천